Plus Therapeutics, Inc.
PSTV
$0.2025
-$0.1061-34.38%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -345.84% | -35.80% | 2.24% | 9.84% | 14.41% |
| Total Depreciation and Amortization | 41.75% | -55.60% | -0.43% | 50.32% | 138.46% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -75.00% | -46.67% |
| Total Other Non-Cash Items | 5,696.76% | 124.49% | 16.24% | -691.57% | -31.01% |
| Change in Net Operating Assets | -160.60% | 1,621.15% | -105.99% | 262.77% | -201.59% |
| Cash from Operations | -409.66% | 67.09% | -220.00% | 74.52% | -139.93% |
| Capital Expenditure | 72.73% | 21.43% | 82.72% | -102.50% | 4.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,608.00% | 1,400.00% | 100.13% | -1,048.46% | -- |
| Cash from Investing | 5,459.38% | 811.11% | 99.76% | -944.51% | -766.67% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -794.03% | 0.00% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -196.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | 997.29% | -46.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 953.62% | 68.91% | -283.44% | 135.57% | -130.55% |